A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Edmonton, Alberta, Canada
- Facility name not stated
London, Ontario, Canada
- Facility name not stated
Newmarket, Ontario, Canada
- Facility name not stated
Greenfield Park, Quebec, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Dothan, Alabama, United States
- Facility name not stated
Montgomery, Alabama, United States
- Facility name not stated
Sacramento, California, United States
- Facility name not stated
Atlantis, Florida, United States
- Facility name not stated
Clearwater, Florida, United States
- Facility name not stated
Fort Myers, Florida, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Sarasota, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Jonesboro, Georgia, United States
- Facility name not stated
Lafayette, Indiana, United States
- Facility name not stated
Paducah, Kentucky, United States
- Facility name not stated
Covington, Louisiana, United States
- Facility name not stated
Annapolis, Maryland, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Randallstown, Maryland, United States
- Facility name not stated
Butte, Montana, United States
- Facility name not stated
Grand Island, Nebraska, United States
- Facility name not stated
Rochester, New York, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Greensboro, North Carolina, United States
- Facility name not stated
Wilmington, North Carolina, United States
- Facility name not stated
Maumee, Ohio, United States
- Facility name not stated
Camp Hill, Pennsylvania, United States
- Facility name not stated
Ephrata, Pennsylvania, United States
- Facility name not stated
Sellersville, Pennsylvania, United States
- Facility name not stated
Rapid City, South Dakota, United States
- Facility name not stated
Fredericksburg, Virginia, United States
- Facility name not stated
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Jan 2014
- Completion
- 31 Mar 2014
- Last update posted
- 26 Feb 2019
- Registered enrollment
- 85
- Registry id
- NCT01662908
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.